Fibromyalgia study links immune system to pain
NCT ID NCT07346950
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 164 women with and without fibromyalgia to see if certain autoantibodies are linked to more severe symptoms. Researchers compared patients with high and low antibody levels, and healthy controls, using questionnaires, blood tests, skin biopsies, and brain scans. The goal was to better understand how the immune system and nervous system interact in fibromyalgia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help explain the biological causes of fibromyalgia and point toward new treatment targets.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not lead to direct therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uppsala University Hospital
Uppsala, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could hidden sleep problems be worsening fibromyalgia?
- Can a nerve zap in the neck tame fibromyalgia pain?
- Could a simple mineral calm the stress of fibromyalgia?
- Unlocking the genetic roots of fibromyalgia's pain puzzle
- Can a single ketamine infusion rewrite the story of fibromyalgia pain?
- Could a probiotic soothe fibromyalgia pain in young people?